BioSpace News Archive

Access to vaccines in New Jersey has increased since the August 2019 inception of a new program between Garden State Pharmacy Owners, Inc. and Horizon Healthcare Services, Inc., which enables patients covered by Horizon commercial insurance to receive immunizations from independent pharmacies in New Jersey..

It can be a bit difficult to predict exactly what the big stories out of the JP Morgan Healthcare Conference are going to be. There’s no telling if some surprise deal will take the air out of the room, but here’s a look at some of the top presentations.

Clinicians and scientists from National Heart Centre Singapore, Duke-NUS Medical School’s Cardiovascular & Metabolic Disorders Programme (CVMD) and SingHealth Duke-NUS Academic Medical Centre (AMC)s’ discovery of a key driver of fibrosis and inflammation in human diseases is now moving rapidly toward the clinic.

BioMed X announced the start of a new joint research group in collaboration with Merck.

Phase Genomics to leverage its proprietary Hi-C technology and analysis software to offer cost-effective, culture-free method to investigate antimicrobial resistance transmission

The makers of CancerStop have gone about their app design in a different way altogether.

Selonterra, Inc., a biotechnology company discovering transformative therapies for neurodegenerative disorders by harnessing human genetics and gene regulatory networks announced a presentation at the Biotech Showcase™ 2020 to be held January 13–15 at the Hilton San Francisco Union Square.

Innate Pharma SA announced a regulatory update regarding its TELLOMAK Phase II trial, evaluating the efficacy and safety of lacutamab in patients with advanced T-cell lymphomas.

WuXi Biologics announced the signing of a strategic collaboration agreement enabling Almirall to leverage the proprietary WuXiBody™ platform to develop bispecific antibodies for dermatological diseases.

Maravai LifeSciences announced that Gregory T. Lucier has been elected to its board of directors.